Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Wasting Syndrome
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Wasting Syndrome
Description
A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism. MeSH
Hierarchy View
Subtype Terms (1)
HIV Wasting Syndrome
8 drugs (7 approved, 1 experimental)
Phase 4 Indicated Drugs (1)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (28)
Innovative Medical Research of South Florida, Inc
Organization Involved with Phase 2 Indications (42)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (28)
All India Institute of Medical Sciences
Cancer Treatment Centers of America
Malteser Krankenhaus Seliger Gerhardt
Medical University of South Carolina
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
